Proteomic-Biostatistic Integrated Approach for Finding the Underlying Molecular Determinants of Hypertension in Human Plasma

Prathibha R. Gajjala, Vera Jankowski, Georg Heinze, Grzegorz Bilo, Alberto Zanchetti, Heidi Noels, Elisa Liehn, Paul Perco, Anna Schulz, Christian Delles, Felix Kork, Erik Biessen, Krzysztof Narkiewicz, Kalina Kawecka-Jaszcz, Juergen Floege, Davide Soranna, Walter Zidek, Joachim Jankowski*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)412-419
Number of pages8
JournalHypertension
Volume70
Issue number2
DOIs
Publication statusPublished - Aug 2017

Keywords

  • antihypertensive agents
  • blood pressure
  • confidence intervals
  • hypertension
  • proteomics
  • CENTER KINASE FAMILY
  • BLOOD-PRESSURE
  • L-TRYPTOPHAN
  • PULMONARY-HYPERTENSION
  • ANTIHYPERTENSIVE DRUGS
  • ARTERIAL-HYPERTENSION
  • OUTCOME INCIDENCE
  • EUROPEAN-SOCIETY
  • TIGHT JUNCTIONS
  • PROTEINS

Cite this

Gajjala, P. R., Jankowski, V., Heinze, G., Bilo, G., Zanchetti, A., Noels, H., Liehn, E., Perco, P., Schulz, A., Delles, C., Kork, F., Biessen, E., Narkiewicz, K., Kawecka-Jaszcz, K., Floege, J., Soranna, D., Zidek, W., & Jankowski, J. (2017). Proteomic-Biostatistic Integrated Approach for Finding the Underlying Molecular Determinants of Hypertension in Human Plasma. Hypertension, 70(2), 412-419. https://doi.org/10.1161/HYPERTENSIONAHA.116.08906